Dror Bashan | President, Chief Executive Officer |
Eyal Rubin | Senior Vice President, Chief Financial Officer |
David Holmes | LifeSci Advisors |
Boobalan Pachaiyappan | HC Wainwright |
John Vandermosten | Zacks Investments |
Good morning ladies and gentlemen and welcome to Protalix BioTherapeutics’ fiscal year 2020 earnings conference call.
As a reminder, this conference call is being recorded. I would now turn the conference over to our host, Mr. David Holmes of LifeSci Advisors Investor Relations.
You may begin your conference, sir.